A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Clinical trial NCT06203210 · RECRUITING
Trial details
- NCT number
- NCT06203210
- Sponsor
- Daiichi Sankyo
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-21
- Primary completion
- 2028-01-30
- Enrollment
- 540
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.